Stay Updated
Press Releases
Patients For Affordable Drugs Launches National Campaign to Pass the CREATES Act
WASHINGTON, D.C. — Patients For Affordable Drugs announced a national campaign to help pass the CREATES Act, a bipartisan bill that would lower drug prices and save taxpayers billions. The legislation prevents brand drug manufacturers from gaming our system and blocking cheaper generic drugs from coming to market. The bill enjoys support from a bipartisan […]
Press Releases
Patients For Affordable Drugs Statement on Governor Brown Signing SB 17
LA PUENTE, CA — The following statement was issued by Victoria Stuessel, a Multiple Sclerosis patient, mother, and La Puente, CA resident seeking relief from skyrocketing drug prices. Victoria is a volunteer Patient Advocate in the Patients For Affordable Drugs community. “Patients like me can breathe a sigh of relief today. For years, I’ve struggled […]
Press Releases
WASHINGTON, DC—Patients For Affordable Drugs applauded a request led by U.S. Senator Maggie Hassan calling on Congress to investigate Allergan’s outrageous legal maneuver to transfer the patent of a blockbuster drug to the St. Regis Mohawk Tribe and maintain its monopoly. The anti-competitive and unprecedented legal dodge by the international drug corporation thwarts the will […]
Press Releases
Statement from Patients For Affordable Drugs on Novartis' Drug Price
WASHINGTON, DC — The following statement was issued by David Mitchell, Founder and President of Patients For Affordable Drugs, regarding Novartis’ decision to price its CAR-T drug, Kymriah, at $475,000 per treatment. “As a cancer patient, the potential of CAR-T is exciting and I applaud FDA’s approval. It means hope for hundreds of children and […]
Press Releases
Patients For Affordable Drugs Launches Campaign Demanding Fair Pricing of New Novartis Cancer Drug
WASHINGTON, DC – Patients for Affordable Drugs launched a national campaign today to demand pharmaceutical giant Novartis price its new cancer drug fairly and in accordance with the fact that American taxpayers invested over $200 million to help discover the drug. In a letter to the CEO of Novartis, Patients For Affordable Drugs requested a […]
Press Releases
Patients For Affordable Drugs Urges FDA to Stop Abuses by Drug Corporations
WASHINGTON, DC – Patients For Affordable Drugs President and founder David Mitchell will urge the Food and Drug Administration (FDA) to take action to boost generic competition and help fix out-of-control drug prices. At a public meeting today, Mitchell will share his story about how the out-of-pocket cost for Revlimid, a cancer drug he took […]
Press Releases
Cancer Patient Sues Big Pharma for Illegal Price Gouging
WASHINGTON, DC – A patient with incurable blood cancer filed a class action lawsuit against Celgene Corporation for abusing consumer safety rules and maintaining a monopoly over its high-cost cancer drugs. The suit alleges Celgene illegally blocked generic development for its highly effective drugs Thalomid and Revlimid—the latter of which costs more than $12,000 for […]
Press Releases
Patients For Affordable Drugs Goes Inside the Belly of the Beast
June 8, 2017 Contact: [email protected] BOSTON, MA – Patients For Affordable Drugs is taking the fight for lower drug prices inside one of America’s biggest drug corporations. Today, Juliana Keeping, the mother of a cystic fibrosis child is headed to Vertex Pharmaceuticals’ annual shareholder meeting to confront company executives about their price gouging tactics and […]